Capsule
TEGO CAPSULES 20MG/5.8MG/19.6MG
Summary
TEGO CAPSULES 20MG/5.8MG/19.6MG — Capsule containing gimeracil, oteracil potassium, tegafur. Hong Kong Registration No. HK-67976. Certificate Holder: LOTUS PHARMACEUTICAL HK LIMITED. Date of Registration: 29 Sep, 2023.
Product NameTEGO CAPSULES 20MG/5.8MG/19.6MG
Registration No.HK-67976
Certificate HolderLOTUS PHARMACEUTICAL HK LIMITED
Holder Address2/F, JONSIM PLACE, NO.228 QUEEN'S ROAD EAST, WAN CHAI, HONG KONG
Ingredientsgimeracil, oteracil potassium, tegafur
Dosage FormCapsule
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration29 Sep, 2023
ATC codesL01BC03
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL01
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。